Loading stock data…
RYTHM (RYM)
$27.48-0.89 (-3.14%)
Market ClosedLast close Jun 29
RYTHM, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
RYTHM, Inc. in the Consumer Defensive sector is trading at $27.48 with a market capitalization of $60M. The stock is currently 49% below its 52-week high of $53.65, remaining 3.8% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $13.29M↑ | $10.66M↑ | $4.04M↑ | $2.04M↑ | $538,000 |
| Gross Profit | $10.40M↑ | $8.04M↑ | $1.38M↑ | $682,000↑ | $90,000 |
| Operating Income | -$4.03M↑ | -$4.48M↑ | -$8.89M↓ | -$6.80M↓ | -$3.70M |
| Net Income | $19.92M↑ | -$13.61M↓ | -$10.66M↓ | -$7.36M↓ | -$1.63M |
Peer Comparison
Fundamentals
RYTHM, Inc. provides solutions for the cannabis and hemp industry in the United States. The company offers consumers hemp-derived tetrahydrocannabinol beverages, as well as other hemp-derived products through retailers, online, and direct-to-retail p...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$60.15M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-32.01%
Volume
Today's trading volume
3,863
Recent News
RYTHM's Q1 Earnings Rise Y/Y on Licensing Agreement Benefits
RYTHM swings to earnings in the first quarter as revenues surge, margins improve and THC beverage demand remains strong, while management projects robust sequential sales growth.
RYTHM's Q4 Loss Narrows Y/Y on Licensing Revenue Growth
RYM's Q4 net loss per share narrows year over year as revenue surged, driven by strong licensing income and expanding distribution of its hemp-derived THC beverages.
Zacks Initiates Coverage of RYTHM With Underperform Recommendation
Find out why Zacks issues an "Underperform" rating on RYM, being the first on Wall Street to initiate coverage on the stock. Explore how mounting debt, persistent losses and legal disputes cloud the outlook despite a pivot to brand-led, capital-light operations.